Cargando…

Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma

Detalles Bibliográficos
Autores principales:	Grogan, Patrick T, Deming, Dustin A, Helgager, Jeffrey, Ruszkiewicz, Theresa, Baskaya, Mustafa K, Howard, Steven P, Robins, H Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Molecular Tumor Board Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167633/ https://www.ncbi.nlm.nih.gov/pubmed/35673607 http://dx.doi.org/10.1093/noajnl/vdac046

Ejemplares similares

The experience of successful treatment of ETV6-NTRK3-positive infant glioblastoma with entrectinib
por: Papusha, Ludmila, et al.
Publicado: (2021)

Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
por: File, Danielle M., et al.
Publicado: (2020)

Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification
por: Hempel, Dirk, et al.
Publicado: (2020)

Using Advanced Molecular Profiling to Identify the Origin of and Tailor Treatment for an Intracranial Mass of Unknown Primary
por: Martinez, Francisco, et al.
Publicado: (2021)

Infantile ZFTA Fusion–Positive Tumor of the Posterior Fossa: Molecular Tumor Board
por: Paulson, Vera A., et al.
Publicado: (2023)

Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers?
por: Hamdan, Diaddin, et al.
Publicado: (2023)

Longitudinal Molecular Analysis of Tumor Exome and Transcriptome to Evaluate Clonal Evolution and Identify Novel Therapeutic Targets in Thymoma
por: Nabel, Christopher S., et al.
Publicado: (2023)

Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response
por: Valiakhmetova, Andge, et al.
Publicado: (2019)

Primary glioblastoma of the cauda equina with molecular and histopathological characterization: Case report
por: Langston, Rebekah G, et al.
Publicado: (2021)

Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation
por: Drumm, Michael, et al.
Publicado: (2022)

H3K27M-mutant, hemispheric diffuse glioma in an adult patient with prolonged survival
por: Chia, Noel, et al.
Publicado: (2021)

Intracranial myxoid mesenchymal neoplasms with EWSR1 gene rearrangement: report of 2 midline cases with one demonstrating durable response to MET inhibitor monotherapy
por: De Los Santos, Yanel, et al.
Publicado: (2021)

Case report: Radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: A report and molecular characterization of two unique cases
por: Grogan, Patrick T., et al.
Publicado: (2023)

Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment
por: Kaplan, Henry G, et al.
Publicado: (2023)

Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC
por: Frampton, James E.
Publicado: (2021)

Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion
por: Beck, Olivia G., et al.
Publicado: (2023)

Correction to: Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC
por: Frampton, James E.
Publicado: (2021)

Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
por: Kurozumi, Kazuhiko, et al.
Publicado: (2022)

Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy‐Refractory Testicular Tumors
por: Lian, Bijun, et al.
Publicado: (2019)

Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation
por: Hou, Zhiwei, et al.
Publicado: (2023)

Entrectinib Induces Apoptosis and Inhibits the Epithelial–Mesenchymal Transition in Gastric Cancer with NTRK Overexpression
por: Sohn, Sung-Hwa, et al.
Publicado: (2021)

Larotrectinib and Entrectinib: TRK Inhibitors for the Treatment of Pediatric and Adult Patients With NTRK Gene Fusion
por: Dunn, Danielle B.
Publicado: (2020)

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
por: Farago, Anna F., et al.
Publicado: (2015)

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors
por: Demetri, George D., et al.
Publicado: (2022)

Sporadic adamantinomatous craniopharyngioma with double-hit somatic APC mutations
por: Hong, Christopher S, et al.
Publicado: (2021)

Use of circulating tumor DNA to guide treatment of primary central nervous system lymphoma: a case report
por: Ho, Ka-wai Grace, et al.
Publicado: (2021)

Spontaneous regression of a congenital high-grade glioma—a case report
por: Riedmeier, Maria, et al.
Publicado: (2021)

Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma
por: Dorostkar, Mario M, et al.
Publicado: (2022)

Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient
por: McCord, Matthew, et al.
Publicado: (2021)

Bone metastases in an adult patient with diffuse midline glioma: a case report
por: Li, Shaoqun, et al.
Publicado: (2020)

Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
por: Ivanidze, Jana, et al.
Publicado: (2021)

IDH-mutant astrocytoma with EGFR amplification—Genomic profiling in four cases and review of literature
por: Umphlett, Melissa, et al.
Publicado: (2022)

Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board
por: Rubens, Jeffrey A, et al.
Publicado: (2022)

An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient
por: Ronsley, Rebecca, et al.
Publicado: (2022)

Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT)
por: Howden, Kaitlyn, et al.
Publicado: (2022)

Diagnostics and prospective outcome of a diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters after surgical resection (DGONC): a case report
por: Howie, Chelsea, et al.
Publicado: (2022)

A case (report) for mechanistic validation of meningioma molecular therapies
por: Nguyen, Minh P, et al.
Publicado: (2022)

MYO5A::FGFR1 represents a novel fusion event in pediatric low-grade glioma
por: Galvin, Robert T, et al.
Publicado: (2023)

Metastatic high-grade meningioma: A case report and review of risk factors for metastasis
por: Bailey, Destiny D, et al.
Publicado: (2023)

Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle
por: Ozkizilkaya, Hanim I, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lb02tsmajkk63q2lp5ve2drrgq